Chemours (CC) Invested Capital (2015 - 2026)

Chemours' Invested Capital history runs 12 years deep, the most recent figure standing at $37.0 million for Q1 2026.

• On a quarterly basis, Invested Capital fell 13.95% year-over-year to $37.0 million in Q1 2026; TTM through Mar 2026 was $96.0 million, a 23.2% decrease from a year earlier, with the FY2025 full-year figure at $42.0 million, down 22.22% from the prior year.
• Invested Capital fell to $37.0 million in Q1 2026 per CC's latest filing, from $42.0 million in the prior quarter.
• Across five years, Invested Capital topped out at $54.0 million in Q4 2024 and bottomed at $8.0 million in Q2 2025.
• The 5-year median for Invested Capital is $24.0 million (2022), against an average of $26.7 million.
• Across the five-year window, Invested Capital soared 250.0% in 2023 and plunged 73.47% in 2024, its largest moves.
• Year by year, Invested Capital stood at $10.0 million in 2022, then jumped by 80.0% to $18.0 million in 2023, then soared by 200.0% to $54.0 million in 2024, then slipped by 22.22% to $42.0 million in 2025, then retreated by 11.9% to $37.0 million in 2026.
• Per Business Quant, the three latest CC Invested Capital figures stand at $37.0 million (Q1 2026), $42.0 million (Q4 2025), and $9.0 million (Q3 2025).